|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Best Practice
Open Access
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Form
Ethics Disclosure form
All issues
Ahead-of Print Articles
Most Read Articles
Most Cited Articles
Radiation Oncology Journal
Search
Author Index
Radiation Oncology Journal
Search
> Browse Articles > Search
Stereotactic radiosurgery for limited brain metastasis using three different techniques: helical tomotherapy, volumetric modulated arc therapy, and cone-based LINAC radiosurgery
Bongkot Jia-Mahasap
, Chakri Madla
, Patumrat Sripan
, Imjai Chitapanarux
, Ekkasit Tharavichitkul
, Somvilai Chakrabandhu
, Pitchayaponne Klunklin
, Wimrak Onchan
Radiat Oncol J.
2022;40(4):232-241. Published online 2022 Dec 26 DOI:
https://doi.org/10.3857/roj.2022.00136
Full text
PubReader
ePub
PDF
Supplementary Material
Web of Science 1
Crossref 1
The using of megavoltage computed tomography in image-guided brachytherapy for cervical cancer: a case report
Ekkasit Tharavichitkul, Suwapim Janla-or, Somsak Wanwilairat, Somvilai Chakrabandhu, Pitchayaponne Klunklin, Wimrak Onchan, Bongkot Supawongwattana, Razvan M. Galalae, Imjai Chitapanarux
Radiat Oncol J.
2015;33(2):155-159. Published online 2015 Jun 30 DOI:
https://doi.org/10.3857/roj.2015.33.2.155
Full text
PubReader
ePub
PDF
Clinical Investigations
The association of rectal equivalent dose in 2 Gy fractions (EQD2) to late rectal toxicity in locally advanced cervical cancer patients who were evaluated by rectosigmoidoscopy in Faculty of Medicine, Chiang Mai University
Ekkasit Tharavichtikul, Pooriwat Meungwong, Taned Chitapanarux, Somvilai Chakrabandhu, Pitchayaponne Klunklin, Wimrak Onchan, Somsak Wanwilairat, Patrinee Traisathit, Razvan Galalae, Imjai Chitapanarux
Radiat Oncol J.
2014;32(2):57-62. Published online 2014 Jun 30 DOI:
https://doi.org/10.3857/roj.2014.32.2.57
Full text
PubReader
ePub
PDF
Web of Science 7
Crossref 6
1
|
Journal Impact Factor 1.8